Free Account Opening + AMC Free Demat
Loading...

Evoq Remedies IPO vs SP Refractories IPO

Comparision between Evoq Remedies IPO and SP Refractories IPO.

IPO Details

Evoq Remedies IPO is a SME Fixed Price Issue IPO proposed to list at BSE SME while SP Refractories IPO is a SME Fixed Price Issue proposed to list at NSE SME.

  Evoq Remedies IPO SP Refractories IPO
Logo Evoq Remedies IPO Logo SP Refractories IPO Logo
Issue Category SME SME
Issue Type IPO IPO
Process Type Fixed Price Issue Fixed Price Issue
Listing At BSE SME NSE SME
Lead Managers Swastika Investmart Ltd Aryaman Financial Services Limited
Registrar Bigshare Services Pvt Ltd Bigshare Services Pvt Ltd
Market Maker
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor
IPO Allotment URL IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Evoq Remedies IPO is up to ₹9.72 Cr whereas the issue size of the SP Refractories IPO is up to ₹4.92 Cr. The final issue price of Evoq Remedies IPO is ₹27.00 per share and of SP Refractories IPO is ₹90.00 per share.

  Evoq Remedies IPO SP Refractories IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower)
Issue Price (Upper)
Issue Price (Final) ₹27.00 per share ₹90.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 4000 shares 1600 shares
Fresh Issue Size 36,00,000 shares 2,97,600 shares
Fresh Issue Size (Amount) up to ₹9.72 Cr up to ₹2.68 Cr
OFS Issue Size 2,49,600 shares
OFS Issue Size (Amount) up to ₹2.25 Cr
Issue Size Total 36,00,000 shares 5,47,200 shares
Issue Size Total (Amount) up to ₹9.72 Cr up to ₹4.92 Cr

IPO Timetable

Evoq Remedies IPO opens on Mar 17, 2022, while SP Refractories IPO opens on Mar 09, 2022. The closing date of Evoq Remedies IPO and SP Refractories IPO is Mar 22, 2022, and Mar 11, 2022, respectively.

  Evoq Remedies IPO SP Refractories IPO
Anchor Bid Date
Issue Open Mar 17, 2022 Mar 09, 2022
Issue Close Mar 22, 2022 Mar 11, 2022
Basis Of Allotment (Tentative) Mar 25, 2022 Mar 16, 2022
Initiation of Refunds (Tentative) Mar 28, 2022 Mar 17, 2022
Credit of Share (Tentative) Mar 29, 2022 Mar 21, 2022
Listing date (Tentative) Mar 30, 2022 Mar 22, 2022
Anchor Lockin End date 1 Apr 24, 2022 Apr 15, 2022
Anchor Lockin End date 2 Jun 23, 2022 Jun 14, 2022

Financials

Evoq Remedies IPO P/E ratio is 33.75, as compared to SP Refractories IPO P/E ratio of 9.94.

  Evoq Remedies IPO SP Refractories IPO
Financial
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (Rs in Lakh)
  10-Feb-22 31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 2660.58 804.63 565.22 214.78
Total Revenue 1056.58 1002.48 907.21 325
Profit After Tax 93.67 71.38 0.03 1.11
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in Lakh)
  30-Sep-21 31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 1,232.20 1,057.17 898.33 792.01
Total Revenue 1,447.64 2,572.48 2,099.59 1,855.95
Profit After Tax 80.74 75.35 39.93 20.59
Promoter Shareholding (Pre-Issue) 99.99% 100%
Promoter Shareholding (Post-Issue) 73.53% 69.42%
P/E Ratio 33.75 9.94
Market Cap ₹36.72 Cr. ₹16.11 Cr.
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Evoq Remedies IPO retail investors (RII) are offered 17,10,000 shares while in SP Refractories IPO retail investors are offered 17,10,000 shares. Qualified institutional buyers (QIB) are offered in Evoq Remedies IPO and in SP Refractories IPO.

  Evoq Remedies IPO SP Refractories IPO
Anchor Investor Reserveration
Market Maker Reserveration 1,80,000 shares 28,800 shares
QIB
NII 17,10,000 shares 2,59,200 shares
RII 17,10,000 shares 2,59,200 shares
Employee
Others
Total 34,20,000 shares 5,18,400 shares

Bids Received (Subscription)

Evoq Remedies IPO subscribed 1.67x in total, whereas SP Refractories IPO subscribed 7.24x.

  Evoq Remedies IPO SP Refractories IPO
QIB (times)
NII (times) 0.30x 5.64x
Big NII (times)
Small NII (times)
RII (times) 3.03x 8.85x
Employee (times)
Other (times)
Total (times) 1.67x 7.24x

Comments

Add a public comment...